Mathis Grossmann
University of Melbourne, VIC, Australia
- This delegate is presenting an abstract at this event.
Professor Mathis Grossmann is a Principal Research Fellow at the Department of Medicine, University of Melbourne, Austin Health. He is a Consultant Endocrinologist and Head of Andrology at Austin Health, where he runs Endocrine Men’s Health and Endocrine Breast Cancer Clinics.
He graduated with an MD from Heidelberg University Medical School and did his internship in Munich, Germany. He then spent 4 years in basic research at the National Institutes of Health, USA, and obtained a PhD at the Walter and Eliza Hall Institute in Melbourne, followed by clinical training leading to FRACP. He joined the University of Melbourne at Austin Health in 2006.
His research focuses on the roles of reproductive hormones in health and disease. His group conducts observational and interventional trials in men with i) low testosterone and chronic disease, ii) hypogonadism, iii) prostate cancer receiving androgen deprivation therapy, and iv) women with breast cancer receiving aromatase inhibition to understand how reproductive hormones regulate musculoskeletal health and glucose homeostasis, both at the clinical and the molecular level.
Presentations this author is a contributor to:
Is Specificity Desirable in Urinary Free Cortisol Measurement? Comparison of 2 Immunoassays and Tandem Mass Spectroscopy. (#102)
1:45 PM
Ingrid Bretherton
ESA - Bryan Hudson Clinical Awards
Sex hormone binding globulin and free testosterone as predictors of mortality in men with type 2 diabetes (#44)
1:30 PM
Henry Wong
ESA Clinical Orals - Men's Health and Case Studies
Effects of Androgen Deprivation on the Biomechanical Function of the Lower-limb Muscles during Gait in Men (#105)
2:30 PM
Ada Cheung
ESA - Bryan Hudson Clinical Awards
Increased fat mass contributes to increased insulin resistance in men undergoing androgen deprivation therapy for prostate cancer. (#221)
5:00 PM
Ada Cheung
ESA Poster Session: Clinical
Histological skeletal muscle changes in men with prostate cancer undergoing androgen deprivation therapy. (#223)
5:00 PM
Casey de Rooy
ESA Poster Session: Clinical
Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy. (#224)
5:00 PM
Casey de Rooy
ESA Poster Session: Clinical